(Q71577597)
Statements
Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients (English)
J Geisler
D Ekse
1 November 1995